Cargando…

Red blood cell distribution width as a novel prognostic marker after myocardial revascularization or cardiac valve surgery

The red blood cell distribution width (RDW) measures the variability in the size of circulating erythrocytes. Previous studies suggested a powerful correlation between RDW obtained from a standard complete blood count and cardiovascular diseases in both primary and secondary cardiovascular preventio...

Descripción completa

Detalles Bibliográficos
Autores principales: Lazzeroni, Davide, Moderato, Luca, Marazzi, P. L., Pellegrino, Carmen, Musiari, Elisa, Castiglioni, Paolo, Camaiora, Umberto, Bini, Matteo, Geroldi, Simone, Brambilla, Lorenzo, Brambilla, Valerio, Coruzzi, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8041885/
https://www.ncbi.nlm.nih.gov/pubmed/33846483
http://dx.doi.org/10.1038/s41598-021-87075-4
_version_ 1783678031107194880
author Lazzeroni, Davide
Moderato, Luca
Marazzi, P. L.
Pellegrino, Carmen
Musiari, Elisa
Castiglioni, Paolo
Camaiora, Umberto
Bini, Matteo
Geroldi, Simone
Brambilla, Lorenzo
Brambilla, Valerio
Coruzzi, Paolo
author_facet Lazzeroni, Davide
Moderato, Luca
Marazzi, P. L.
Pellegrino, Carmen
Musiari, Elisa
Castiglioni, Paolo
Camaiora, Umberto
Bini, Matteo
Geroldi, Simone
Brambilla, Lorenzo
Brambilla, Valerio
Coruzzi, Paolo
author_sort Lazzeroni, Davide
collection PubMed
description The red blood cell distribution width (RDW) measures the variability in the size of circulating erythrocytes. Previous studies suggested a powerful correlation between RDW obtained from a standard complete blood count and cardiovascular diseases in both primary and secondary cardiovascular prevention. The current study aimed to evaluate the prognostic role of RDW in patients undergoing cardiac rehabilitation after myocardial revascularization and/or cardiac valve surgery. The study included 1.031 patients with available RDW levels, prospectively followed for a mean of 4.5 ± 3.5 years. The mean age was 68 ± 12 years, the mean RDW was 14.7 ± 1.8%; 492 patients (48%) underwent cardiac rehabilitation after myocardial revascularization, 371 (36%) after cardiac valve surgery, 102 (10%) after valve-plus-coronary artery by-pass graft surgery, 66 (6%) for other indications. Kaplan–Meier analysis and Cox hazard analysis were used to associate RDW with mortality. Kaplan–Meier analysis demonstrated worse survival curves free from overall (log-rank p < 0.0001) and cardiovascular (log-rank p < 0.0001) mortality in the highest RDW tertile. Cox analysis showed RDW levels correlated significantly with the probability of overall (HR 1.26; 95% CI 1.19–1.32; p < 0.001) and cardiovascular (HR 1.31; 95% CI 1.23–1.40; p < 0.001) mortality. After multiple adjustments for cardiovascular risk factors, hemoglobin, hematocrit, C-reactive protein, microalbuminuria, atrial fibrillation, glomerular filtration rate,left ventricular ejection fraction and number of exercise training sessions attended, the increased risk of overall (HR 1.10; 95% CI 1.01–1.27; p = 0.039) and cardiovascular (HR 1.13; 95% CI 1.01–1.34; p = 0.036)mortality with increasing RDW values remained significant. The RDW represents an independent predictor of overall and cardiovascular mortality in secondary cardiovascular prevention patients undergoing cardiac rehabilitation.
format Online
Article
Text
id pubmed-8041885
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-80418852021-04-13 Red blood cell distribution width as a novel prognostic marker after myocardial revascularization or cardiac valve surgery Lazzeroni, Davide Moderato, Luca Marazzi, P. L. Pellegrino, Carmen Musiari, Elisa Castiglioni, Paolo Camaiora, Umberto Bini, Matteo Geroldi, Simone Brambilla, Lorenzo Brambilla, Valerio Coruzzi, Paolo Sci Rep Article The red blood cell distribution width (RDW) measures the variability in the size of circulating erythrocytes. Previous studies suggested a powerful correlation between RDW obtained from a standard complete blood count and cardiovascular diseases in both primary and secondary cardiovascular prevention. The current study aimed to evaluate the prognostic role of RDW in patients undergoing cardiac rehabilitation after myocardial revascularization and/or cardiac valve surgery. The study included 1.031 patients with available RDW levels, prospectively followed for a mean of 4.5 ± 3.5 years. The mean age was 68 ± 12 years, the mean RDW was 14.7 ± 1.8%; 492 patients (48%) underwent cardiac rehabilitation after myocardial revascularization, 371 (36%) after cardiac valve surgery, 102 (10%) after valve-plus-coronary artery by-pass graft surgery, 66 (6%) for other indications. Kaplan–Meier analysis and Cox hazard analysis were used to associate RDW with mortality. Kaplan–Meier analysis demonstrated worse survival curves free from overall (log-rank p < 0.0001) and cardiovascular (log-rank p < 0.0001) mortality in the highest RDW tertile. Cox analysis showed RDW levels correlated significantly with the probability of overall (HR 1.26; 95% CI 1.19–1.32; p < 0.001) and cardiovascular (HR 1.31; 95% CI 1.23–1.40; p < 0.001) mortality. After multiple adjustments for cardiovascular risk factors, hemoglobin, hematocrit, C-reactive protein, microalbuminuria, atrial fibrillation, glomerular filtration rate,left ventricular ejection fraction and number of exercise training sessions attended, the increased risk of overall (HR 1.10; 95% CI 1.01–1.27; p = 0.039) and cardiovascular (HR 1.13; 95% CI 1.01–1.34; p = 0.036)mortality with increasing RDW values remained significant. The RDW represents an independent predictor of overall and cardiovascular mortality in secondary cardiovascular prevention patients undergoing cardiac rehabilitation. Nature Publishing Group UK 2021-04-12 /pmc/articles/PMC8041885/ /pubmed/33846483 http://dx.doi.org/10.1038/s41598-021-87075-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Lazzeroni, Davide
Moderato, Luca
Marazzi, P. L.
Pellegrino, Carmen
Musiari, Elisa
Castiglioni, Paolo
Camaiora, Umberto
Bini, Matteo
Geroldi, Simone
Brambilla, Lorenzo
Brambilla, Valerio
Coruzzi, Paolo
Red blood cell distribution width as a novel prognostic marker after myocardial revascularization or cardiac valve surgery
title Red blood cell distribution width as a novel prognostic marker after myocardial revascularization or cardiac valve surgery
title_full Red blood cell distribution width as a novel prognostic marker after myocardial revascularization or cardiac valve surgery
title_fullStr Red blood cell distribution width as a novel prognostic marker after myocardial revascularization or cardiac valve surgery
title_full_unstemmed Red blood cell distribution width as a novel prognostic marker after myocardial revascularization or cardiac valve surgery
title_short Red blood cell distribution width as a novel prognostic marker after myocardial revascularization or cardiac valve surgery
title_sort red blood cell distribution width as a novel prognostic marker after myocardial revascularization or cardiac valve surgery
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8041885/
https://www.ncbi.nlm.nih.gov/pubmed/33846483
http://dx.doi.org/10.1038/s41598-021-87075-4
work_keys_str_mv AT lazzeronidavide redbloodcelldistributionwidthasanovelprognosticmarkeraftermyocardialrevascularizationorcardiacvalvesurgery
AT moderatoluca redbloodcelldistributionwidthasanovelprognosticmarkeraftermyocardialrevascularizationorcardiacvalvesurgery
AT marazzipl redbloodcelldistributionwidthasanovelprognosticmarkeraftermyocardialrevascularizationorcardiacvalvesurgery
AT pellegrinocarmen redbloodcelldistributionwidthasanovelprognosticmarkeraftermyocardialrevascularizationorcardiacvalvesurgery
AT musiarielisa redbloodcelldistributionwidthasanovelprognosticmarkeraftermyocardialrevascularizationorcardiacvalvesurgery
AT castiglionipaolo redbloodcelldistributionwidthasanovelprognosticmarkeraftermyocardialrevascularizationorcardiacvalvesurgery
AT camaioraumberto redbloodcelldistributionwidthasanovelprognosticmarkeraftermyocardialrevascularizationorcardiacvalvesurgery
AT binimatteo redbloodcelldistributionwidthasanovelprognosticmarkeraftermyocardialrevascularizationorcardiacvalvesurgery
AT geroldisimone redbloodcelldistributionwidthasanovelprognosticmarkeraftermyocardialrevascularizationorcardiacvalvesurgery
AT brambillalorenzo redbloodcelldistributionwidthasanovelprognosticmarkeraftermyocardialrevascularizationorcardiacvalvesurgery
AT brambillavalerio redbloodcelldistributionwidthasanovelprognosticmarkeraftermyocardialrevascularizationorcardiacvalvesurgery
AT coruzzipaolo redbloodcelldistributionwidthasanovelprognosticmarkeraftermyocardialrevascularizationorcardiacvalvesurgery